We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Infectious Diseases

Infectious Diseases

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Culture-Negative Infective Endocarditis in the Modern Diagnostic Era: Patient Characteristics and Heterogeneity in a Nationwide Cohort
CardiologyCardiologyculture-negative infection

Culture-Negative Infective Endocarditis in the Modern Diagnostic Era: Patient Characteristics and Heterogeneity in a Nationwide Cohort

By MedXY|Jun 10, 2026

A nationwide Danish study found that culture-negative infective endocarditis was less common than previously reported, often presented without fever or sepsis, and showed higher embolic risk. PET-CT was especially useful in prosthetic valve

When a Stomach Bug Doesn’t End: The Hidden Global Burden of Post-Infection Gut Disorders
Gastroenterologychronic digestive symptomsgastroenteritis

When a Stomach Bug Doesn’t End: The Hidden Global Burden of Post-Infection Gut Disorders

By MedXY|Jun 10, 2026

A major global study shows that some people develop lasting gut-brain disorders after acute gastroenteritis, linking infections to chronic digestive and psychological symptoms.

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation
Gastroenterologychronic hepatitis Bcirrhosis

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation

By MedXY|Jun 10, 2026

In NA-treated cirrhotic chronic hepatitis B with complete viral suppression, HBsAg seroclearance was linked to lower HCC risk but not lower hepatic decompensation, reinforcing functional cure as a meaningful but incomplete clinical endpoint

Swedish Population Data Suggest SARS-CoV-2 Infection and COVID-19 Vaccination Do Not Confer a Sustained Causal Risk of New-Onset Type 1 Diabetes
Diabetes & EndocrinologyCOVID-19 vaccinationPopulation Study

Swedish Population Data Suggest SARS-CoV-2 Infection and COVID-19 Vaccination Do Not Confer a Sustained Causal Risk of New-Onset Type 1 Diabetes

By MedXY|Jun 7, 2026

In a nationwide Swedish cohort, type 1 diabetes diagnoses rose briefly after SARS-CoV-2 infection and first vaccine dose, but the signal was short-lived, supporting diagnostic acceleration rather than a durable causal effect.

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset
Critical Careantimicrobial therapycritical care

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset

By MedXY|Jun 5, 2026

In critically ill ICU patients with confirmed bacterial infections, appropriate empiric antimicrobial therapy was common and independently linked to lower 28-day mortality and more antimicrobial-free days.

Digital Shared Decision Support Increased STI Testing for Adolescents and Young Adults in the Emergency Department
Emergency Medicineadolescent healthemergency department

Digital Shared Decision Support Increased STI Testing for Adolescents and Young Adults in the Emergency Department

By MedXY|May 30, 2026

In a randomized controlled trial, the STIckER smartphone-based decision aid increased gonorrhea/chlamydia and pharyngeal STI testing in emergency department patients aged 14 to 24 years, while improving decisional clarity, satisfaction, and

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors
Dermatologyatopic dermatitisInfection Risk

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors

By MedXY|May 27, 2026

A large meta-analysis found JAK-STAT inhibitors slightly increased influenza, bronchitis, and herpes zoster risk, especially in atopic dermatitis, while serious and opportunistic infections were not significantly increased.

Rapid Respiratory Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial
Family Medicine & Nutritionantibiotic stewardshipPoint-of-Care Testing

Rapid Respiratory Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial

By MedXY|May 26, 2026

A randomized trial found that rapid respiratory point-of-care testing did not reduce same-day antibiotic prescribing in primary care, though it was safe and may help when a virus is detected.

Diabetes, Male Sex, and Low HBsAg, HDV RNA, and ALT Predict Spontaneous HDV Suppression in Chronic Hepatitis D
GastroenterologyALTchronic hepatitis D

Diabetes, Male Sex, and Low HBsAg, HDV RNA, and ALT Predict Spontaneous HDV Suppression in Chronic Hepatitis D

By MedXY|May 20, 2026

In 1,610 untreated chronic hepatitis D patients, spontaneous HDV suppression was uncommon but increased over time. Diabetes, male sex, and lower baseline HBsAg, HDV RNA, and ALT predicted suppression and fewer liver-related events.

Lower Airway Dysbiosis in NTM-Positive Bronchiectasis Is Linked to NET-Dominant Severe Phenotypes
Infectious Diseasesairway microbiomebronchiectasis

Lower Airway Dysbiosis in NTM-Positive Bronchiectasis Is Linked to NET-Dominant Severe Phenotypes

By MedXY|May 18, 2026

In NTM-positive bronchiectasis, lower airway dysbiosis involving Mycobacterium and oral bacteria is linked to higher NET levels and more severe disease phenotypes, suggesting that the broader airway microbiome may shape inflammation and out

New SCCM–ESICM Consensus Defines Refractory Septic Shock
Critical CareConsensuscritical care

New SCCM–ESICM Consensus Defines Refractory Septic Shock

By MedXY|May 15, 2026

A new SCCM–ESICM Delphi consensus standardizes clinical criteria for refractory septic shock, focusing on persistent hypoperfusion, fluid unresponsiveness, high vasopressor needs, and bedside ultrasound when mixed shock is suspected.

First-Trimester Maternal CMV Infection Concentrates the Risk of Fetal Brain Injury, Hearing Loss, and Autism Spectrum Disorder
Infectious Diseasesfetal MRIfirst trimester

First-Trimester Maternal CMV Infection Concentrates the Risk of Fetal Brain Injury, Hearing Loss, and Autism Spectrum Disorder

By MedXY|Aug 18, 2026

A large prospective cohort suggests that long-term sequelae of congenital CMV after primary maternal infection are confined to first-trimester exposure, with autism spectrum disorder linked to temporal lobe white matter abnormalities.

Bone Marrow Immune Profiling Identifies a Practical Infection Risk Score in Multiple Myeloma
Hematology-Oncologyimmune biomarkersInfection Risk

Bone Marrow Immune Profiling Identifies a Practical Infection Risk Score in Multiple Myeloma

By MedXY|May 9, 2026

A large multicenter study links specific bone marrow immune cell patterns to infection risk in multiple myeloma and proposes a clinically relevant immune score that may support minimally invasive monitoring.

Whole-Genome Sequencing Suggests Casual Community Contact Drives Much of Drug-Resistant Tuberculosis Transmission in Durban
Infectious Diseasescasual contactdrug-resistant tuberculosis

Whole-Genome Sequencing Suggests Casual Community Contact Drives Much of Drug-Resistant Tuberculosis Transmission in Durban

By MedXY|May 9, 2026

A molecular epidemiology study in Durban found that casual community contact, not only household or named contacts, accounted for a substantial share of drug-resistant tuberculosis transmission.

“Never More Than 15 Feet From the Respirator”: Housestaff Research During the 1955 Boston Polio Epidemic
Infectious DiseasesMedical Educationmedical history

“Never More Than 15 Feet From the Respirator”: Housestaff Research During the 1955 Boston Polio Epidemic

By MedXY|May 5, 2026

During Boston’s devastating 1955 polio epidemic, Massachusetts General Hospital trainees conducted groundbreaking patient research while providing round-the-clock care in iron lung wards – a striking contrast to trainee roles during C

Pairing HDV RNA With Anti-HDV Levels May Sharpen Staging and Treatment Monitoring in HBV/HDV Coinfection
Gastroenterologyanti-HDVHDV RNA

Pairing HDV RNA With Anti-HDV Levels May Sharpen Staging and Treatment Monitoring in HBV/HDV Coinfection

By MedXY|May 4, 2026

In HBsAg-positive, anti-HDV-positive patients, combined measurement of HDV RNA and anti-HDV titers distinguished inactive from active disease and tracked interferon response more effectively than either marker alone.

Elevated Heart Failure Risk in People With HIV: Insights from the REPRIEVE Trial
Cardiologycardiovascular riskheart failure

Elevated Heart Failure Risk in People With HIV: Insights from the REPRIEVE Trial

By MedXY|Apr 30, 2026

The REPRIEVE trial reveals higher heart failure incidence in people with HIV, particularly among women, Black participants in high-income regions, and those with hypertension or obesity. Traditional risk factors, not HIV-specific markers, w

Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes
Critical Carebiomarkersdisease tolerance

Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes

By MedXY|Apr 27, 2026

A prospective cohort study identifies biomarker signatures for host resistance, disease tolerance, and damage in sepsis, revealing associations with mortality and sepsis subtypes.

Fecal Microbiota Transplant Fails to Decolonize Multidrug-Resistant Organisms in GI Patients: A Randomized Trial Analysis
GastroenterologyAntimicrobial ResistanceFecal microbiota transplant

Fecal Microbiota Transplant Fails to Decolonize Multidrug-Resistant Organisms in GI Patients: A Randomized Trial Analysis

By MedXY|Apr 27, 2026

A randomized clinical trial found that FMT did not significantly decolonize MDROs or reduce AMR genes in GI disease patients, though it modulated gut microbiome composition.

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity
GastroenterologyADCCHBV

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity

By MedXY|Apr 25, 2026

A study reveals CD16+ γδ T cells as key mediators of antibody-dependent cellular cytotoxicity in HBV infection, correlating with reduced viral replication and offering new therapeutic targets.

Prev
4 / 17
123456…17
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles